1. Home
  2. PALT vs PMCB Comparison

PALT vs PMCB Comparison

Compare PALT & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PALT
  • PMCB
  • Stock Information
  • Founded
  • PALT 1998
  • PMCB 1996
  • Country
  • PALT United States
  • PMCB United States
  • Employees
  • PALT 17
  • PMCB N/A
  • Industry
  • PALT EDP Services
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PALT Technology
  • PMCB Health Care
  • Exchange
  • PALT Nasdaq
  • PMCB Nasdaq
  • Market Cap
  • PALT 16.1M
  • PMCB 13.9M
  • IPO Year
  • PALT N/A
  • PMCB N/A
  • Fundamental
  • Price
  • PALT $1.80
  • PMCB $1.72
  • Analyst Decision
  • PALT Hold
  • PMCB
  • Analyst Count
  • PALT 1
  • PMCB 0
  • Target Price
  • PALT N/A
  • PMCB N/A
  • AVG Volume (30 Days)
  • PALT 45.0K
  • PMCB 56.4K
  • Earning Date
  • PALT 11-12-2024
  • PMCB 12-13-2024
  • Dividend Yield
  • PALT N/A
  • PMCB N/A
  • EPS Growth
  • PALT N/A
  • PMCB N/A
  • EPS
  • PALT N/A
  • PMCB 0.54
  • Revenue
  • PALT $9,635,475.00
  • PMCB N/A
  • Revenue This Year
  • PALT N/A
  • PMCB N/A
  • Revenue Next Year
  • PALT $3.52
  • PMCB N/A
  • P/E Ratio
  • PALT N/A
  • PMCB $3.21
  • Revenue Growth
  • PALT N/A
  • PMCB N/A
  • 52 Week Low
  • PALT $1.67
  • PMCB $1.39
  • 52 Week High
  • PALT $5.50
  • PMCB $2.58
  • Technical
  • Relative Strength Index (RSI)
  • PALT 36.66
  • PMCB 49.02
  • Support Level
  • PALT $1.68
  • PMCB $1.57
  • Resistance Level
  • PALT $1.94
  • PMCB $1.92
  • Average True Range (ATR)
  • PALT 0.17
  • PMCB 0.15
  • MACD
  • PALT 0.03
  • PMCB -0.01
  • Stochastic Oscillator
  • PALT 21.63
  • PMCB 50.00

About PALT Paltalk Inc.

Paltalk Inc is a communications software innovator. It operates a network of consumer applications where users can meet, see, chat, broadcast and message in real-time in a secure environment with others in the network. The company's product portfolio includes Paltalk, Camfrog, Tinychat and Vumber. Its consumer applications generate revenue principally from subscription fees and advertising arrangements. The company's majority revenue is generated from live video chat products that are :Paltalk and Camfrog.

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

Share on Social Networks: